APA (7th ed.) Citation

J, Z., H, C., & J, S. (2024). Dendritic Cell-Related Immune Marker CD1C for Predicting Prognosis and Immunotherapy Opportunities of Lung Adenocarcinoma Patients. Applied biochemistry and biotechnology, 196(12), 8724. https://doi.org/10.1007/s12010-024-04973-9

Chicago Style (17th ed.) Citation

J, Zhao, Chen H, and Sun J. "Dendritic Cell-Related Immune Marker CD1C for Predicting Prognosis and Immunotherapy Opportunities of Lung Adenocarcinoma Patients." Applied Biochemistry and Biotechnology 196, no. 12 (2024): 8724. https://doi.org/10.1007/s12010-024-04973-9.

MLA (9th ed.) Citation

J, Zhao, et al. "Dendritic Cell-Related Immune Marker CD1C for Predicting Prognosis and Immunotherapy Opportunities of Lung Adenocarcinoma Patients." Applied Biochemistry and Biotechnology, vol. 196, no. 12, 2024, p. 8724, https://doi.org/10.1007/s12010-024-04973-9.